仿真抗原受体NK细胞的免疫疗法:现状及其有前途的未来
Fang Wang1, Zhaoyuan Huang1, Xiaoming Feng2,3,4
1Department of Hematology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Frontiers in immunology
|November 17, 2025
概括
化学抗原受体 (CAR) 自然杀手 (NK) 细胞疗法对固体瘤有希望,克服了CAR T细胞的局限性. 研究正在推进CAR NK细胞的发展,以便在更广泛的临床应用中使用.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞工程 细胞工程
背景情况:
- 化学抗原受体 (CAR) T细胞疗法对血液癌症有效,但在固体瘤方面面临挑战.
- 固体瘤存在一些困难,包括抗原稀缺,细胞贩运和透限制.
- 自然杀手 (NK) 细胞由于其细胞毒性和安全性,因此具有癌症治疗的潜力.
研究的目的:
- 审查CAR NK细胞免疫疗法的优点.
- 综合当前关于CAR NK细胞治疗固体瘤的研究.
- 解决阻碍CARNK细胞临床采用的挑战.
主要方法:
- 对CAR T细胞和CAR NK细胞免疫疗法的现有文献的综述.
- 对CAR T细胞治疗固体瘤的挑战进行分析.
- 检查NK细胞特性和CAR工程策略.
主要成果:
- 卡尔NK细胞为固体瘤治疗提供了一个有希望的替代方案.
- NK细胞具有固有的细胞毒性和有利的安全性.
- 诸如活体内持久性和生产复杂性的挑战需要进一步研究.
结论:
- 卡尔NK细胞免疫疗法在治疗固体瘤方面具有显著的潜力.
- 克服NK细胞持久性和制造障碍对于临床成功至关重要.
- 需要进一步的研究来优化CAR NK细胞疗法.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:27Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K